Nuvei Becomes Direct Local Acquirer in Canada
Canada Day 2025 announcement highlights expanded local capabilities and Nuvei’s global direct acquiring strategy MONTREAL, June 30, 2025 /PRNewswire/ —... Read more.
TELUS Announces Upsizing and Results of its Cash Tender Offers for Eight Series of Debt Securities
VANCOUVER, BC, June 30, 2025 /PRNewswire/ – TELUS Corporation (the “Company”) today announced (i) the release of the results of its previously... Read more.
Edward Jones to Acquire Natixis Investment Managers’ Overlay Management Services Capabilities
Deal is intended to further bolster the firm’s ability to provide comprehensive financial planning and investment management services for clients and add deeper... Read more.
UltiMaker Launches MakerBot Nebula: An AI-Powered Differentiated Learning Platform for Education
The new platform, currently in beta, is designed to enhance STEM learning through smart tools, educator resources, and personalized learning for students. Applications... Read more.
How One Small Nonprofit Reinvented Itself Through Multimedia Storytelling–and Earned National Recognition
SAN RAMON, Calif., June 30, 2025 /PRNewswire/ — The Surplus Line Association of California (SLA) is showing that even niche nonprofits can transform how they... Read more.
OneOdio Unveils Focus A6: Latest ANC Headphones with CNC-Milled Aviation-grade Aluminum Alloy CD Patterns
NEW YORK, June 30, 2025 /PRNewswire/ — OneOdio, a global leader in audio innovation, proudly announces the launch of the Focus A6, its most premium and design-forward... Read more.
The Home Depot Enters Into Agreement for SRS Distribution to Acquire GMS
Expands Distribution Offerings and Capabilities for Pro Customers MCKINNEY, Texas and ATLANTA, June 30, 2025 /PRNewswire/ — The Home Depot®, the world’s... Read more.
Intensity Therapeutics, Inc. Announces that INT230-6 Achieved 100% Complete Response Rate in Preclinical Models of Malignant Peripheral Nerve Sheath Tumors (MPNST)
SHELTON, Conn., June 30, 2025 /PRNewswire/ — Intensity Therapeutics, Inc. (Nasdaq: INTS) (“Intensity” or “the Company”), a late-stage... Read more.
Tyra Biosciences Doses First Patient in Phase 2 Study of TYRA-300 in Low-Grade Intermediate Risk Non-Muscle Invasive Bladder Cancer (SURF302)
–TYRA-300 is the only orally administered investigational agent in clinical development for IR NMIBC- -Initial 3-month complete response (CR) data expected... Read more.
DailyPay Completes Inaugural Asset-Backed Securitization, Powering Its Mission To Break The Paycheck-To-Paycheck Cycle For Millions of Workers
DailyPay Creates New Asset Class, Closes $200 Million Securitization of its On-Demand Pay Receivables To Support Top Employers In Ending The Archaic Two-Week Pay... Read more.